Back to announcement
20240705_INAF_Laporan Informasi dan Fakta Material_31680303.pdf
Financial statement Text extracted INAFSource file signed link, expires in 15 minutes
Extracted text 4
Page 1
Go To English Page
Nomor Surat 1114/DIR/VII/2024
Nama Perusahaan Indofarma Tbk.
Kode Emiten INAF
Lampiran 2
Penyampaian Laporan Keuangan
Perihal
Tahun Fiskal : 2023
Tahun Buku : DEC
Jenis Periode : Tahunan / Annual
Dengan ini kami untuk dan atas nama perusahaan menyampaikan laporan keuangan, sebagai berikut:
Nama Emiten : Indofarma Tbk.
Bidang Usaha : Industri Farmasi dan Kesehatan
Nilai Ekuitas : (804.152.258.266)
Nilai Pendapatan Periode Sebelumnya : 980.370.552.490
Nilai Pendapatan : 523.599.087.434
Selisih dengan Nilai Pendapatan (456,771)
:
Periode Sebelumnya
Kurs : Rupiah / IDR
Rate : 1
Jenis Laporan atas Laporan Keuangan : Diaudit / Audited
Opini Audit : Wajar Dengan Pengecualian / Qualified
Demikian untuk diketahui.
Hormat Kami,
Indofarma Tbk.
Warjoko Sumedi
Corporate Secretary
Indofarma Tbk.
Jl. Indofarma No. 1, Cikarang Barat, Bekasi, 17530
Telepon : (021) 8832 3971/75; 8590 8349/50, Fax : (021) 8832 3972/73; 857 4503 ,
Nama Pengirim Warjoko Sumedi
Jabatan Corporate Secretary
Page 2
Tanggal dan Waktu 05-07-2024 15:37
Lampiran 1. Laporan Keuangan 2023 PT. Indofarma Tbk.pdf
2. S-1114 Penyampaian Laporan Keuangan 2023.pdf
Dokumen ini merupakan dokumen resmi Indofarma Tbk. yang tidak memerlukan tanda tangan karena dihasilkan
secara elektronik oleh sistem pelaporan elektronik. Indofarma Tbk. bertanggung jawab penuh atas informasi yang
tertera didalam dokumen ini.
Page 3
Go To Indonesian Page
Letter / Announcement No. 1114/DIR/VII/2024
Issuer Name Indofarma Tbk.
Issuer Code INAF
Attachment 2
Subject Submission of Financial Report
Fiscal Year : 2023
End of Year : DEC
Period Type : Tahunan / Annual
The company hereby announce the Submission of Financial Report as follows:
Issuer Name : Indofarma Tbk.
Business Fields : Industri Farmasi dan Kesehatan
Equity Value : (804.152.258.266)
Previous Period Revenue : 980.370.552.490
Revenue : 523.599.087.434
Difference with Previous Period (456,771)
:
Revenue
Currency : Rupiah / IDR
Rate : 1
Types of Reports on Financial : Diaudit / Audited
Type of Auditor's Opinion : Wajar Dengan Pengecualian / Qualified
Thus to be informed accordingly.
Respectfully,
Indofarma Tbk.
Warjoko Sumedi
Corporate Secretary
Indofarma Tbk.
Jl. Indofarma No. 1, Cikarang Barat, Bekasi, 17530
Phone : (021) 8832 3971/75; 8590 8349/50, Fax : (021) 8832 3972/73; 857 4503 ,
Sender Name Warjoko Sumedi
Function Corporate Secretary
Page 4
Date and Time 05-07-2024 15:37
Attachment 1. Laporan Keuangan 2023 PT. Indofarma Tbk.pdf
2. S-1114 Penyampaian Laporan Keuangan 2023.pdf
This is an official document of Indofarma Tbk. that does not require a signature as it was generated electronically
by the electronic reporting system. Indofarma Tbk. is fully responsible for the information contained within this
document.
Names mentioned 2 people and organisations named in the text · linked when the evidence is strong
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.